(Q37954227)

25 August 2017

title

Safety aspects of antiepileptic drugs--focus on pharmacovigilance (English)

1 reference

Cecilie Johannessen Landmark

25 August 2017

author

series ordinal

1

object named as

Cecilie Johannessen Landmark

1 reference

25 August 2017

2

Svein I Johannessen

1 reference

25 August 2017

publication date

8 November 2011

1 reference

Pharmacoepidemiology and Drug Safety

25 August 2017

published in

1 reference

25 August 2017

volume

21

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

11-20

1 reference

Adverse drug reactions: definitions, diagnosis, and management

25 August 2017

cites work

1 reference

Considerations in the choice of an antiepileptic drug in the treatment of epilepsy

21 January 2018

1 reference

An introduction to antiepileptic drugs

21 January 2018

1 reference

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy

21 January 2018

1 reference

Trends in utilization of antiepileptic drugs in Denmark

21 January 2018

1 reference

Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005.

21 January 2018

1 reference

Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions

21 January 2018

1 reference

Antiepileptic drugs in Australia: 2002-2007.

21 January 2018

1 reference

Visual field defects with vigabatrin: epidemiology and therapeutic implications

21 January 2018

1 reference

Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.

21 January 2018

1 reference

Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase

21 January 2018

1 reference

Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis

21 January 2018

1 reference

Use and safety profile of antiepileptic drugs in Italy.

21 January 2018

1 reference

Confusion, a rather serious adverse drug reaction with valproic acid: a review of the French Pharmacovigilance database

21 January 2018

1 reference

Safety profile of oxcarbazepine: results from a prescription-event monitoring study

21 January 2018

1 reference

Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in England

21 January 2018

1 reference

The safety and effectiveness of newer antiepileptics: a comparative postmarketing cohort study

21 January 2018

1 reference

Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study

21 January 2018

1 reference

Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy

21 January 2018

1 reference

Pharmacists' role in reporting adverse drug reactions in an international perspective

21 January 2018

1 reference

Characteristics and quality of adverse drug reaction reports by pharmacists in Norway

21 January 2018

1 reference

Adverse drug reaction reporting by patients in the Netherlands: three years of experience

21 January 2018

1 reference

Suicidality in epilepsy and possible effects of antiepileptic drugs

21 January 2018

1 reference

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death

21 January 2018

1 reference

Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior

21 January 2018

1 reference

Psychiatric comorbidity and suicidal behavior in epilepsy: a community-based case-control study.

21 January 2018

1 reference

Antiepileptic drugs and suicidality. Much ado about very little?

21 January 2018

1 reference

On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios

21 January 2018

1 reference

Psychiatric comorbidity in patients with epilepsy: a population-based study

21 January 2018

1 reference

Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population.

21 January 2018

1 reference

Assessment of potential drug interactions in patients with epilepsy: impact of age and sex.

21 January 2018

1 reference

Epilepsy mortality and risk factors for death in epilepsy: a population-based study

21 January 2018

1 reference

Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs

21 January 2018

1 reference

Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands

21 January 2018

1 reference

Changing trends in antiepileptic drug prescribing in girls of child-bearing potential.

21 January 2018

1 reference

Comparison of antiepileptic drug prescribing in children in three European countries

21 January 2018

1 reference

Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07

21 January 2018

1 reference

Sociodemographic differences in antiepileptic drug prescriptions to adult epilepsy patients

21 January 2018

1 reference

Value of therapeutic drug monitoring in epilepsy

21 January 2018

1 reference

Drug interactions involving the new second- and third-generation antiepileptic drugs

21 January 2018

1 reference

Antiepileptic drug interactions - principles and clinical implications

21 January 2018

1 reference

Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?

21 January 2018

1 reference

Are lamotrigine kinetics altered in menopause? Observations from a drug monitoring database

21 January 2018

1 reference

Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions

21 January 2018

1 reference

Trends and changes in the clinical use of lamotrigine.

21 January 2018

1 reference

Possible drug-drug interaction between quetiapine and lamotrigine--evidence from a Swedish TDM database

21 January 2018

1 reference

Oral contraceptives reduce lamotrigine plasma levels

21 January 2018

1 reference

Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age.

21 January 2018

1 reference

Antiepileptic drug treatment in children

21 January 2018

1 reference

Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium

21 January 2018

1 reference

Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study

21 January 2018

1 reference

Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites

21 January 2018

1 reference

Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium

21 January 2018

1 reference

Seizure deterioration in women treated with oxcarbazepine during pregnancy.

21 January 2018

1 reference

Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations

21 January 2018

1 reference

Serum concentration/dose ratio of topiramate during pregnancy

21 January 2018

1 reference

Pharmacokinetics of topiramate during pregnancy

21 January 2018

1 reference

Serum concentration/dose ratio of levetiracetam before, during and after pregnancy

21 January 2018

1 reference

Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: clinical and outcome implications

21 January 2018

1 reference

Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance

21 January 2018

1 reference

Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts

21 January 2018

1 reference

Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry

21 January 2018

1 reference

Antiepileptic drug teratogenesis: what are the risks for congenital malformations and adverse cognitive outcomes?

21 January 2018

1 reference

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

21 January 2018

1 reference

The teratogenic risk of antiepileptic drug polytherapy

21 January 2018

1 reference

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

21 January 2018

1 reference

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

Changing patterns of antiepileptic drug use in pregnant Australian women

21 January 2018

1 reference

Antiepileptic drug use in women of childbearing age.

21 January 2018

1 reference

Pregnancy registries: differences, similarities, and possible harmonization

21 January 2018

1 reference

Sudden unexpected death in epilepsy (SUDEP): a clinical perspective and a search for risk factors

21 January 2018

1 reference

Sudden unexpected death in epilepsy (SUDEP): update and reflections.

21 January 2018

1 reference

Mortality rates and causes of death in children with epilepsy prescribed antiepileptic drugs: a retrospective cohort study using the UK General Practice Research Database

21 January 2018

1 reference

Sudden unexpected death in epilepsy: current knowledge and future directions

21 January 2018

1 reference

Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommit

21 January 2018

1 reference

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of N

21 January 2018

1 reference

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommitt

21 January 2018

1 reference

Reporting of adverse drug reactions by nurses

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.2269

1 reference

25 August 2017

1 reference